NMR(NMR)
NMR
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $2.33T | $2.40T | $2.47T | $2.21T |
| Low | $2.20T | $2.13T | $2.33T | $2.08T |
| High | $2.45T | $2.65T | $2.60T | $2.32T |
| EBITDA Avg | $293.77B | $303.06B | $311.20B | $278.41B |
| Low | $276.88B | $269.29B | $293.30B | $262.40B |
| High | $309.32B | $334.14B | $327.67B | $293.15B |
| EBIT Avg | $240.88B | $248.50B | $255.17B | $228.29B |
| Low | $227.03B | $220.81B | $240.50B | $215.16B |
| High | $253.63B | $273.99B | $268.68B | $240.37B |
| Net Income Avg | $444.05B | $450.01B | $464.66B | $437.17B |
| Low | $410.86B | $416.37B | $429.92B | $404.50B |
| High | $474.60B | $480.97B | $496.63B | $467.25B |
| EPS Avg | $145.91 | $147.87 | $152.68 | $143.65 |
| Low | $135.00 | $136.81 | $141.27 | $132.91 |
| High | $155.95 | $158.04 | $163.18 | $153.53 |
| Analysts (Rev / EPS) | 1 / 1 | 6 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $587.66B | $612.88B | $640.08B | $647.28B | $655.60B | $664.01B | $672.51B | $672.28B |
| Low | $587.66B | $612.88B | $640.08B | $647.28B | $655.60B | $664.01B | $672.51B | $672.28B |
| High | $587.66B | $612.88B | $640.08B | $647.28B | $655.60B | $664.01B | $672.51B | $672.28B |
| EBITDA Avg | $74.13B | $77.31B | $80.74B | $81.65B | $82.70B | $83.76B | $84.83B | $84.80B |
| Low | $74.13B | $77.31B | $80.74B | $81.65B | $82.70B | $83.76B | $84.83B | $84.80B |
| High | $74.13B | $77.31B | $80.74B | $81.65B | $82.70B | $83.76B | $84.83B | $84.80B |
| EBIT Avg | $60.78B | $63.39B | $66.20B | $66.95B | $67.81B | $68.68B | $69.56B | $69.53B |
| Low | $60.78B | $63.39B | $66.20B | $66.95B | $67.81B | $68.68B | $69.56B | $69.53B |
| High | $60.78B | $63.39B | $66.20B | $66.95B | $67.81B | $68.68B | $69.56B | $69.53B |
| Net Income Avg | $112.34B | $115.91B | $120.17B | $109.99B | $111.94B | $113.92B | $115.95B | $109.09B |
| Low | $112.34B | $115.91B | $120.17B | $109.99B | $111.94B | $113.92B | $115.95B | $109.09B |
| High | $112.34B | $115.91B | $120.17B | $109.99B | $111.94B | $113.92B | $115.95B | $109.09B |
| EPS Avg | $37.31 | $38.49 | $39.91 | $36.53 | $37.17 | $37.83 | $38.51 | $36.23 |
| Low | $37.31 | $38.49 | $39.91 | $36.53 | $37.17 | $37.83 | $38.51 | $36.23 |
| High | $37.31 | $38.49 | $39.91 | $36.53 | $37.17 | $37.83 | $38.51 | $36.23 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |